Stochastic variation in network epidemic models: implications for the design of community level HIV prevention trials

Important sources of variation in the spread of HIV in communities arise from overlapping sexual networks and heterogeneity in biological and behavioral risk factors in populations. These sources of variation are not routinely accounted for in the design of HIV prevention trials. In this paper, we use agent-based models to account for these sources of variation. We illustrate the approach with an agent-based model for the spread of HIV infection among men who have sex with men in South Africa. We find that traditional sample size approaches that rely on binomial (or Poisson) models are inadequate and can lead to underpowered studies. We develop sample size and power formulas for community randomized trials that incorporate estimates of variation determined from agent-based models. We conclude that agent-based models offer a useful tool in the design of HIV prevention trials.

[1]  T. Quinn,et al.  Behavioral and biomedical combination strategies for HIV prevention. , 2012, Cold Spring Harbor perspectives in medicine.

[2]  Michael Rayment,et al.  Prevention of HIV-1 infection with early antiretroviral therapy , 2012, Journal of Family Planning and Reproductive Health Care.

[3]  A. Winsor Sampling techniques. , 2000, Nursing times.

[4]  B. Marx Iteratively reweighted partial least squares estimation for generalized linear regression , 1996 .

[5]  Tobi Saidel,et al.  Review of sampling hard-to-reach and hidden populations for HIV surveillance. , 2005, AIDS.

[6]  Stefan D Baral,et al.  Global epidemiology of HIV infection in men who have sex with men , 2012, The Lancet.

[7]  C. Beyrer,et al.  HIV Risk and Associations of HIV Infection among men who have sex with men in Peri-Urban Cape Town, South Africa , 2011, BMC public health.

[8]  M. Gail,et al.  Aspects of statistical design for the Community Intervention Trial for Smoking Cessation (COMMIT). , 1992, Controlled clinical trials.

[9]  Valérie Buthion,et al.  ColoNav: patient navigation for colorectal cancer screening in deprived areas – Study protocol , 1999, BMC Cancer.

[10]  Peter L. Anderson,et al.  Emtricitabine-Tenofovir Concentrations and Pre-Exposure Prophylaxis Efficacy in Men Who Have Sex with Men , 2012, Science Translational Medicine.

[11]  S. Lagakos,et al.  Challenges to HIV prevention--seeking effective measures in the absence of a vaccine. , 2008, The New England journal of medicine.

[12]  Matthew J. Salganik Variance Estimation, Design Effects, and Sample Size Calculations for Respondent-Driven Sampling , 2006, Journal of Urban Health.

[13]  E H Wagner,et al.  Data analysis and sample size issues in evaluations of community-based health promotion and disease prevention programs: a mixed-model analysis of variance approach. , 1991, Journal of clinical epidemiology.

[14]  Victor DeGruttola,et al.  Editorial commentary: network epidemic models: assumptions and interpretations. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  Amy H Auchincloss,et al.  A new tool for epidemiology: the usefulness of dynamic-agent models in understanding place effects on health. , 2008, American journal of epidemiology.

[16]  P. Holland,et al.  An Exponential Family of Probability Distributions for Directed Graphs , 1981 .

[17]  P M Fayers,et al.  Cluster-randomized trials , 2002, Palliative medicine.

[18]  B. Koblin Effects of a behavioural intervention to reduce acquisition of HIV infection among men who have sex with men: the EXPLORE randomised controlled study , 2004, The Lancet.

[19]  Joshua M. Epstein,et al.  Agent-based computational models and generative social science , 1999, Complex..

[20]  David V Glidden,et al.  Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. , 2010, The New England journal of medicine.

[21]  Alex Carballo-Diéguez,et al.  Successes and challenges of HIV prevention in men who have sex with men , 2012, The Lancet.

[22]  W. El-Sadr,et al.  HIV Prevention: Great Achievements, More Challenges Ahead , 2013, Journal of acquired immune deficiency syndromes.

[23]  Gail E. Potter,et al.  The Transmissibility and Control of Pandemic Influenza A (H1N1) Virus , 2009, Science.

[24]  R. Hayes,et al.  Simple sample size calculation for cluster-randomized trials. , 1999, International journal of epidemiology.

[25]  F. Hsieh,et al.  Sample size formulae for intervention studies with the cluster as unit of randomization. , 1988, Statistics in medicine.

[26]  Eric Bonabeau,et al.  Agent-based modeling: Methods and techniques for simulating human systems , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Joshua M. Epstein,et al.  Containing a large bioterrorist smallpox attack: a computer simulation approach. , 2007, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[28]  S. Lagakos,et al.  Methodological challenges in biomedical HIV prevention trials. , 2008 .

[29]  Allan Donner,et al.  Design and Analysis of Cluster Randomization Trials in Health Research , 2001 .

[30]  V. De Gruttola,et al.  Sample size considerations in the design of cluster randomized trials of combination HIV prevention , 2014, Clinical trials.

[31]  R. Mayeux,et al.  Epidemiology of Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.

[32]  A. Donner,et al.  Randomization by cluster. Sample size requirements and analysis. , 1981, American journal of epidemiology.

[33]  S. Goodreau,et al.  Sexual role and transmission of HIV Type 1 among men who have sex with men, in Peru. , 2005, The Journal of infectious diseases.

[34]  A. Nizam,et al.  Containing Bioterrorist Smallpox , 2002, Science.